A Phase 3/4, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH) (The ARMOR Study)”, Galmed Pharmaceutical-ARMOR Study-Protocol No. 018, 2019.